Serious neonatal morbidity or perinatal death · third trimester induction of labour in women with a viable fetus
It is very uncertain whether balloon (Foley or ATAD) changes serious neonatal morbidity or perinatal death compared with low‐dose vaginal misoprostol (very low certainty).
1 finding from 1 review
Serious neonatal morbidity or perinatal death · third trimester induction of labour in women with a viable fetus
Balloon (Foley or ATAD) showed no clear difference in serious neonatal morbidity or perinatal death compared with low‐dose oral misoprostol (low certainty).
1 finding from 1 review
Serious neonatal morbidity or perinatal death · third trimester induction of labour in women with a viable fetus
Balloon (Foley or ATAD) probably leads to lower serious neonatal morbidity or perinatal death compared with vaginal prostaglandin E2 (moderate certainty).
1 finding from 1 review
Serious neonatal morbidity or perinatal death · pregnant women with a previous low transverse caesarean section, singleton live pregnancy with cephalic presentation, period of gestation…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious neonatal morbidity or perinatal death · women with a previous caesarean section (subgroup of all women in the study) with intact fetal membranes, cephalic position and…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious neonatal morbidity or perinatal death · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious neonatal morbidity or perinatal death · pregnant women with 1 previous lower segment caesarean section at 37 weeks and beyond, with a BS of ≤ 6, intact membranes, reactive…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious neonatal morbidity or perinatal death · pregnant women who previously had a lower segment CS and now have a singleton cephalic presentation after at least 36 completed weeks, not…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious neonatal morbidity or perinatal death · women with a previous caesarean section, a live singleton fetus (37‐42 weeks of gestation) in cephalic presentation and a reactive…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious neonatal morbidity or perinatal death · women with one previous lower segment caesarean section and requiring labour induction due to prolonged pregnancy or pre‐eclampsia,…
Vaginal PGE2 showed no clear difference in serious neonatal morbidity/perinatal death compared with intravenous (IV) oxytocin (low certainty).
1 finding from 1 review
Serious neonatal morbidity or perinatal death · women with a previous caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious neonatal morbidity or perinatal death · pregnant women undergoing cervical ripening and induction of labour
Nitric oxide donors showed no clear difference in serious neonatal morbidity/perinatal death compared with placebo (low certainty).
1 finding from 1 review
Serious neonatal morbidity or perinatal death · patients with induction of labour at term
(7.1) PGE2 (controlled release) showed no clear difference in serious neonatal morbidity or perinatal death compared with all PGE2 delivery systems (all women) (low certainty).
1 finding from 1 review
Serious neonatal morbidity or perinatal death · patients with induction of labour at term
PGE2 showed no clear difference in serious neonatal morbidity or perinatal death compared with placebo or no treatment (low certainty).
1 finding from 1 review
Neonatal death or serious neonatal perinatal morbidity · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
Amniotic membranes sweeping showed no clear difference in neonatal death or serious neonatal perinatal morbidity compared with vaginal/intracervical prostaglandins (low certainty).
1 finding from 1 review
Neonatal death or serious neonatal perinatal morbidity · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neonatal death or serious neonatal perinatal morbidity · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
One frequency of amniotic membranes sweeping showed no clear difference in neonatal death or serious neonatal perinatal morbidity compared with another frequency of amniotic membrane sweeping (low certainty).
1 finding from 1 review
Neonatal death or serious neonatal perinatal morbidity · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
Amniotic membranes sweeping showed no clear difference in neonatal death or serious neonatal perinatal morbidity compared with no treatment/sham (low certainty).
1 finding from 1 review
Serious neonatal morbidity or perinatal death · women with a twin pregnancy
Planned caesarean section showed no clear difference in perinatal or neonatal death or serious neonatal morbidity compared with planned vaginal birth (moderate certainty).
1 finding from 1 review
Neonatal death or serious neonatal perinatal morbidity · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found